Mesa Laboratories, Inc. (MLAB) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MLAB Revenue Growth
Revenue Breakdown (FY 2025)
MLAB's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
MLAB Revenue Analysis (2014–2025)
As of May 8, 2026, Mesa Laboratories, Inc. (MLAB) generated trailing twelve-month (TTM) revenue of $247.5 million, reflecting modest growth of +3.6% year-over-year. The most recent quarter (Q3 2026) recorded $65.1 million in revenue, up 7.2% sequentially.
Looking at the longer-term picture, MLAB's 5-year compound annual growth rate (CAGR) stands at +15.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $241.0 million in 2025, representing a new all-time high.
Revenue diversification analysis shows MLAB's business is primarily driven by Product (82%), and Service (18%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Technology sector peers including NEOG (-3.7% YoY), LFUS (+12.6% YoY), and NOVT (+3.3% YoY), MLAB has underperformed the peer group in terms of revenue growth. Compare MLAB vs NEOG →
MLAB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MLABCurrent | $248M | +3.6% | +15.4% | 6.8% | |
 NEOG | $895M | -3.7% | +16.4% | 1.1% | |
 LFUS | $2.4B | +12.6% | +10.5% | 1.6% | |
 NOVT | $981M | +3.3% | +10.7% | 11.9% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% | |
 TRMB | $3.6B | +3.2% | +2.6% | 16.9% |
MLAB Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $241.0M | +11.5% | $150.9M | 62.6% | $16.3M | 6.8% |
| 2024 | $216.2M | -1.3% | $133.3M | 61.6% | $-272,075,000 | -125.9% |
| 2023 | $219.1M | +18.8% | $133.7M | 61.0% | $3.3M | 1.5% |
| 2022 | $184.3M | +37.6% | $109.1M | 59.2% | $4.7M | 2.6% |
| 2021 | $133.9M | +13.8% | $87.0M | 65.0% | $12.4M | 9.2% |
| 2020 | $117.7M | +14.1% | $65.4M | 55.5% | $7.9M | 6.7% |
| 2019 | $103.1M | +7.2% | $60.9M | 59.1% | $9.8M | 9.5% |
| 2018 | $96.2M | +2.7% | $54.6M | 56.8% | $2.2M | 2.3% |
| 2017 | $93.7M | +10.6% | $53.2M | 56.8% | $16.3M | 17.4% |
| 2016 | $84.7M | +18.7% | $51.4M | 60.7% | $16.3M | 19.3% |
See MLAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MLAB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MLAB vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonMLAB — Frequently Asked Questions
Quick answers to the most common questions about buying MLAB stock.
Is MLAB's revenue growth accelerating or slowing?
MLAB revenue growth slowed to +3.6%, below the 5-year CAGR of +15.4%. TTM revenue is $248M. The deceleration marks a shift from historical growth rates.
What is MLAB's long-term revenue growth rate?
Mesa Laboratories, Inc.'s 5-year revenue CAGR of +15.4% reflects the variable expansion pattern. Current YoY growth of +3.6% is near this long-term average.
How is MLAB's revenue distributed by segment?
MLAB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.